These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26829850)

  • 21. Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.
    An WQ; Yang PH; Duan YQ; Luo DY; Tang C; Jia WH; Xing L; Shi XF; Zhang YJ; Liu XF; Wang XL
    Chin Med J (Engl); 2009 Dec; 122(23):2880-5. PubMed ID: 20092795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutations in the genes coding for hemagglutinin and neuraminidase in cold-adapted variants of the influenza virus A/Leningrad/134/57 (H2N2)].
    Medvedeva TE; Kudriavtseva VK; Zhikhareva IV; Romashkina VV; Aleksandrova GI; Klimov AI
    Vopr Virusol; 1991; 36(2):96-100. PubMed ID: 1882532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
    Shcherbik S; Carney P; Pearce N; Stevens J; Dugan VG; Wentworth DE; Bousse T
    Virology; 2018 Sep; 522():65-72. PubMed ID: 30014859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characterization of influenza virus reassortants based on new donor strain A/HK/1/68/162/35(H3N2)].
    Potapchuk MV; Repko IA; Sergeeva MV; Korotkov AV; Komissarov AB; Sandybaev NT; Cherviakova OV; Khaĭrullin VM; Tsybalova LM
    Vopr Virusol; 2012; 57(6):42-6. PubMed ID: 23477254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis of live-attenuated influenza virus.
    He W; Wang W; Han H; Wang L; Zhang G; Gao B
    PLoS One; 2013; 8(3):e60413. PubMed ID: 23555969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
    Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
    PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.
    Murphy BR; Holley HP; Berquist EJ; Levine MM; Spring SB; Maassab HF; Kendal AP; Chanock RM
    Infect Immun; 1979 Feb; 23(2):253-9. PubMed ID: 422240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets.
    Yang P; Duan Y; Wang C; Xing L; Gao X; Tang C; Luo D; Zhao Z; Jia W; Peng D; Liu X; Wang X
    Vaccine; 2011 Jan; 29(4):698-705. PubMed ID: 21111782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.
    Rodriguez L; Blanco-Lobo P; Reilly EC; Maehigashi T; Nogales A; Smith A; Topham DJ; Dewhurst S; Kim B; Martínez-Sobrido L
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31658679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
    Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B live influenza vaccine].
    Kiseleva IV; Larionova NV; Voeten JT; Teley LC; Drieszen-van der Cruijsen SK; Heldens JG; van den Bosch JF; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):41-7. PubMed ID: 21381376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Live cold-adapted influenza vaccine: state-of-the-art].
    Gendon IuZ
    Vopr Virusol; 2011; 56(1):4-17. PubMed ID: 21427948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain.
    Wareing MD; Marsh GA; Tannock GA
    Vaccine; 2002 May; 20(16):2082-90. PubMed ID: 11972977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.
    Krutikova EV; Stepanova EA; Wong PF; Kiseleva IV; Grigor'eva EP; Rudenko LG
    Bull Exp Biol Med; 2020 Mar; 168(5):669-672. PubMed ID: 32248454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
    Wohlgemuth N; Ye Y; Fenstermacher KJ; Liu H; Lane AP; Pekosz A
    Vaccine; 2017 Dec; 35(48 Pt B):6691-6699. PubMed ID: 29079099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3].
    Desheva IuA; Smolonogina TA; Sergeeva MV; Rekstin AR; Swayne D; Klimov AI; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):31-6. PubMed ID: 19340965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live cold-adapted influenza A vaccine produced in Vero cell line.
    Romanova J; Katinger D; Ferko B; Vcelar B; Sereinig S; Kuznetsov O; Stukova M; Erofeeva M; Kiselev O; Katinger H; Egorov A
    Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.